Definitions of cytomegalovirus infection and disease in transplant recipients

被引：948

作者：

Ljungman, P ^{[1
]}

Griffiths, P

Paya, C

机构：

[1] Huddinge Univ Hosp, Dept Hematol, Karolinska Inst, SE-14186 Stockholm, Sweden

[2] UCL Royal Free & Univ Coll Med Sch, Dept Virol, London, England

[3] Mayo Clin, Dept Infect Dis, Rochester, MN USA

[4] Mayo Clin, Transplant Ctr, Rochester, MN USA

来源：

CLINICAL INFECTIOUS DISEASES | 2002年 / 34卷 / 08期

关键词：

D O I：

10.1086/339329

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Cytomegalovirus (CMV) infection and disease are important causes of morbidity and mortality among transplant recipients. For the purpose of developing consistent reporting of CMV in clinical trials, definitions of CMV infection and disease were developed and published. This study seeks to update the definitions of CMV on the basis of recent developments in diagnostic techniques, as well as to add to these definitions the concept of indirect effects caused by CMV.

引用

页码：1094 / 1097

页数：4

共 19 条

[1] OBLITERATIVE BRONCHIOLITIS AFTER LUNG AND HEART-LUNG TRANSPLANTATION - AN ANALYSIS OF RISK-FACTORS AND MANAGEMENT [J].

BANDO, K ;

PARADIS, IL ;

SIMILO, S ;

KONISHI, H ;

KOMATSU, K ;

ZULLO, TG ;

YOUSEM, SA ;

CLOSE, JM ;

ZEEVI, A ;

DUQUESNOY, RJ ;

MANZETTI, J ;

KEENAN, RJ ;

ARMITAGE, JM ;

HARDESTY, RL ;

GRIFFITH, BP .

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1995, 110 (01) :4-14

[2]

FIETZE E, 1994, TRANSPLANTATION, V58, P675

[3] The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients [J].

George, MJ ;

Snydman, DR ;

Werner, BG ;

Griffith, J ;

Falagas, ME ;

Dougherty, NN ;

Rubin, RH .

AMERICAN JOURNAL OF MEDICINE, 1997, 103 (02) :106-113

[4] CYTOMEGALO-VIRUS INFECTION IS ASSOCIATED WITH CARDIAC ALLOGRAFT-REJECTION AND ATHEROSCLEROSIS [J].

GRATTAN, MT ;

MORENOCABRAL, CE ;

STARNES, VA ;

OYER, PE ;

STINSON, EB ;

SHUMWAY, NE .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (24) :3561-3566

[5] Cytomegalovirus infection-enhanced cardiac allograft vasculopathy is abolished by DHPG prophylaxis in the rat [J].

Lemstrom, K ;

Sihvola, R ;

Bruggeman, C ;

Hayry, P ;

Koskinen, P .

CIRCULATION, 1997, 95 (12) :2614-2616

[6] CYTOMEGALOVIRUS ANTIGEN EXPRESSION, ENDOTHELIAL-CELL PROLIFERATION, AND INTIMAL THICKENING IN RAT CARDIAC ALLOGRAFTS AFTER CYTOMEGALOVIRUS-INFECTION [J].

LEMSTROM, K ;

KOSKINEN, P ;

KROGERUS, L ;

DAEMEN, M ;

BRUGGEMAN, C ;

HAYRY, P .

CIRCULATION, 1995, 92 (09) :2594-2604

[7]

LJUNGMAN P, 1995, SCAND J INFECT DIS S, V99, P87

[8]

Ljungman P., 1993, EXCERPTA MED INT C S, P233

[9]

LOEBE M, 1990, J HEART TRANSPLANT, V9, P707

[10] Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation [J].

Lowance, D ;

Neumayer, HH ;

Legendre, CM ;

Squifflet, JP ;

Kovarik, J ;

Brennan, PJ ;

Norman, D ;

Mendez, R ;

Keating, MR ;

Coggon, GL ;

Crisp, A ;

Lee, IC .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (19) :1462-1470

← 1 2 →